RE:RE:RE:RE:My concern
You make a good point!
This isn't information we should have to pry to be supplied
with.Considering we as investors who have made every effort to find out all we can dig out how
bc works,effectiveness, tolerences, sales etc and have few credible answers? This isn't a
bash just a sad fact! The average consumer/customer will not be willing to go to these lengths to
get answers to all these disconnects in verification of operations to fork over $15000 a unit. I
know I wouldn't chase them for information...it just creates senseless doubt and nonconfidence
in the product and Company. It's become very obvious theres little to no consideration being
given to share holders after their last "update" which told us absolutely nothing and actually
implied zero interest in Biocloud. Other than maybe some original investors that were given
access to a conference call some time ago. I'm stuck at a 50% loss so we wait in hopes this
carnival has a happy ending. I am also very dissapointed they don't have Bc's in all their outlets
as well as distributers and promoting the product as creating a safe workplace! GL